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Planar 123I-MIBG (meta-iodobenzylguanidine) cardiac imaging is listed as an indicative biomarker in 
the 2017 international consensus criteria for the diagnosis of dementia with Lewy bodies.  There has 
been very little research into the relationship between apparent cardiac uptake and patient size, or in 
the possible advantage of attenuation and scatter corrected SPECT-CT compared to planar imaging.  
We aimed to evaluate this in both a chest phantom and in older adults with normal cognition. 
Materials and Methods: 
An anthropomorphic chest phantom was filled with 123I solution using activities typical of healthy 
subjects.  The phantom was scanned on a Siemens Intevo gamma camera with MELP collimators using 
both planar and SPECT-CT techniques.  Further scans were acquired with a PMMA chest plate added, 
then water filled plastic breasts.  The SPECT-CT images were reconstructed using a resolution recovery 
OSEM method with and without attenuation and scatter correction (ACSC) applied. 
Twenty-nine adults over 60 years of age (mean 75.2 ± 8.3 years) underwent planar cardiac MIBG 
imaging, followed by SPECT-CT.  SPECT images were reconstructed as above. Heart-to-mediastinum 
ratios (HMRs) were calculated for planar and SPECT images.   
Results:  
Phantom planar HMR decreased by 20% with the PMMA chest plate added; 39% with plate and 
breasts.  ACSC SPECT cardiac counts showed less dependence on phantom size than SPECT without 
ACSC (3% vs 37%).  The body mass indices (BMI) of the older adults ranged from 22 to 38. There was 
a significant linear relationship between planar HMR and BMI (R2=0.44, p<0.01), but not for ACSC 
SPECT.  However, there was no significant difference between the slopes for planar and ACSC SPECT 
(p=0.11).   
Conclusion: 
Planar cardiac 123I-MIBG HMR results are correlated with BMI.  Phantom results suggest that ACSC 
SPECT can correct for patient size.  A large patient population or clinical database would be required 





Dementia with Lewy bodies (DLB) is the second most common form of neurodegenerative dementia 
after Alzheimer’s disease, accounting for 5-10% of cases [1, 2].  Accurate diagnosis is important for 
clinical management, prognosis, and carer wellbeing [3-5], but initial misdiagnosis outside the 
specialist setting is common [2, 6, 7].  Cardiac MIBG sympathetic innervation imaging is an established 
technique for the differential diagnosis of DLB from other dementias, which do not cause sympathetic 
denervation and thus have normal scan appearances [8-10].   The technique has been used in Japan 
for the diagnosis of Lewy body disease for over a decade and was recently included as an indicative 
biomarker in the fourth DLB consensus criteria, alongside 123I-FP-CIT SPECT [6].   Cardiac MIBG 
scintigraphy is also used for the estimation of risk of sudden cardiac death in heart failure patients and 
predicting those who could benefit from an implantable cardiac defibrillator (ICD) [11, 12] and this is 
currently the principal application in Europe and the US [13].   
Several authors have commented on the need to standardise cardiac MIBG image acquisition and 
processing parameters in order for cardiac uptake thresholds to be applicable between centres, e.g. 
[14-19].  A method to correct for differences in image acquisition parameters between centres 
(predominantly caused by different gamma camera and collimator models) has been developed by 
Nakajima et al. [20] was used in the multicentre study mentioned above [21, 22].  However, technical 
factors such as variation in the amount of attenuation and scatter due to patient size, cannot be taken 
into account with this method.  There have been few publications commenting on whether patient 
factors may have a significant impact on diagnostic value of planar cardiac MIBG scintigraphy, and to 
our knowledge none that have explored whether SPECT with CT attenuation and scatter correction 
(CTACSC) would be of benefit.  Although several groups investigating the diagnostic accuracy of cardiac 
123I-MIBG for the diagnosis of Lewy body disease have acquired SPECT data alongside planar, often it 
is only the planar scans that have been used for analysis with the SPECT results not reported [23-27], 
suggesting the added value of SPECT is unclear.  In 2016 Odagiri et al. reported that the accuracies of 
planar and SPECT-CT 123I-MIBG cardiac scintigraphy were similar, but did not appear to use the CT data 
for SPECT image corrections, only for localising the heart [28].  In their 2015 multicentre study, Yoshita 
et al. used SPECT for visual analysis but not for quantification of cardiac uptake [21]. 
Obesity has been linked to decreased apparent cardiac MIBG uptake by two previous studies [29, 30], 
and is thought to be due to increased attenuation and scatter in larger individuals, rather than to true 
differences in cardiac uptake.  The largest study of healthy controls recruited to a cardiac MIBG 
research study (n=94) was that of Jacobsen et al. [31] carried out as part of the ADMIRE heart failure 
study [11].  The controls were aged between 29 to 82 years (mean 58.5 ± 10.6 years, with a wide BMI 
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range of 20.4 to 44.3 kg/m2 (mean 28.7 ± 5.1).  The study reported a “modest” decrease in HMR with 
BMI, however this was a study into ageing and the incidental finding of a relationship between BMI 
and HMR was not discussed in detail.  Pellegrino et al. reported lower HMRs in patients with BMI>30 
(n=10) compared to those with BMI<30 (n=35) [30].  This was in heart failure patients and the results 
have not yet been replicated in healthy controls but do suggest patient size may affect apparent 
cardiac MIBG uptake.   
In this study we aimed to establish the degree to which planar cardiac I-123-MIBG scintigraphy is 
affected by patient size and whether SPECT with CTACSC can correct for this.  We investigated this 
using an anthropomorphic chest phantom configured with different amounts of attenuation and a 
cohort of older adults with normal cognition with BMI between 22 and 38 kg/m2. 
Materials and methods 
Inclusion criteria for older adults 
Twenty-nine volunteers aged between 62 and 94 years (mean 75.2 ± 8.3 years) were recruited as part 
of an ongoing Newcastle University study into cardiac MIBG in a representative UK population of older 
adults.  They underwent a detailed neurological and cognitive examination by a research physician 
with a detailed medical history taken.  All volunteers had normal cognition, no evidence of 
parkinsonism and normal MRI brain scans.  We did not recruit anyone with Class II or worse heart 
failure according to the New York Heart Association classification, who had experienced a myocardial 
infarction in the previous year or were taking tramadol.  As we aimed to recruit a representative 
sample of older people, we did not exclude those with diabetes or other risk factors for cardiac disease 
such as smoking or raised blood pressure. 
Image acquisition 
The volunteers were administered 111 MBq I-123-MIBG via slow intravenous injection.  Potassium 
iodate tablets (170mg) were given before and after injection to minimise uptake of free iodine by the 
thyroid.  Ten minute anterior planar images were acquired at 4 hours (± 30 minutes) after injection.  
SPECT-CT imaging was carried out immediately after the delayed planar image with the subject in the 
supine position with arms raised if possible.  Only ten of the volunteers were able to be scanned with 
arms raised, the others kept their arms by their sides.  All images were acquired on a dual headed 
Siemens Symbia Intevo hybrid SPECT-CT gamma camera (Siemens Healthcare, Munich, Germany) 
using medium energy low penetration (MELP) collimators.  For planar imaging the energy window was 
159 keV ± 10%, matrix size was 128 x 128 and no zoom was applied, resulting in a pixel size of 4.8 mm.  
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SPECT images were acquired over 360 degrees in H mode (detectors oriented parallel to each other) 
to obtain 120 projections of 20 seconds using a non-circular autocontoured orbit. The energy window 
was 159 keV ± 7.5%, matrix size 64 x 64 and zoom factor 1.64.  Following SPECT imaging, a low dose 
CT scan (130 kV with a quality reference mAs of 13) was acquired for attenuation and scatter 
correction. 
Image reconstruction 
All images were processed on a Hermes workstation (Hermes Medical Ltd, Stockholm Sweden), to 
obtain results generalisable to different gamma camera models.    SPECT images were processed in 
Hermes Hybrid Recon Cardiology v1.1.2 using OSEM iterative reconstruction with 15 iterations and 3 
subsets, with a Butterworth filter of 0.90 cm applied.  Resolution recovery collimator modelling for 
the MELP collimator was applied, with parameters set for the Siemens Intevo gamma camera as 
provided by Hermes: hole diameter 0.294 cm; hole length 4.06 cm; detector intrinsic resolution at 140 
keV 0.38 cm ; radius of rotation off-set 4.76 cm.    Two sets of images were reconstructed, both using 
resolution recovery: non-corrected (NC) and CT corrected for attenuation and scatter (ACSC).  The 
voxel size was 6.6 mm.  The scatter correction model is based on a Monte Carlo simulation of scatter 
within the patient [32, 33].  Full collimator and detector response modelling [34] is not included in this 
model. 
Phantom image acquisition  
Images were acquired with the RSD torso phantom (Radiology Support Devices Ltd, Long Beach, CA, 
USA), with fillable heart, lung, liver and background compartments (Figure 1).  The original heart insert 
supplied with the phantom did not give realistic-looking cardiac MIBG images so was substituted with 
a simple left ventricle insert manufactured in-house with fillable myocardial wall and cavity 
compartments.  The phantom was filled and scanned with I-123, using activity concentrations 
designed to mimic patient studies.  The activities used are given in Table 1. The left ventricle insert 
was imaged alone on the scanner bed without any additional attenuation followed by three filled 
phantom scans with increasing amounts of attenuation: torso phantom, torso phantom with solid 
PMMA chest extension plate and torso phantom with chest plate and breasts (plastic shells filled with 
water) – see Figure 1. 
The scan parameters were the same as those used for clinical research studies at our centre: MELP 
collimators, auto-contouring, 1.64 zoom, 64 x64 matrix size.  As with clinical scans, CT scans allow for 
both attenuation and scatter corrected and non-corrected images to be reconstructed..   
Images were reconstructed using the clinical parameters given above. 
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Figure 1: Anthropomorphic torso phantom (centre), with in-house replacement LV insert (left) and additional PMMA chest 
plate and water filled breasts (right) 
Table 1: activity concentrations used in the anthropomorphic torso phantom, selected to give count densities similar to 
healthy control images. 
 Activity  (MBq) Activity 
concentration 




LV dose (diluted 
into 200 ml, actual 
volume ~160 ml) 
27.7 138.7 22 
Background 
(approx. 8200 ml) 
52.6 6.4 1 
Liver (1000 ml) 78.6 78.6 12.2 
Lungs (diluted in 
1000 ml before 
filling) 
50.1 50.1 7.8 
 
Image analysis for cardiac uptake 
The images of the torso phantom and the images of the older adult volunteers were analysed in the 
same way.  Anterior planar images were analysed to obtain the heart to mediastinum ratio (HMR) 
using a 6 cm circular ROI placed over the left ventricle and 4 x 3 cm rectangular ROI between the lungs 
in the mediastinum, see [35].  The phantom was not moved from the scanner couch between 
acquisitions, allowing the same regions to be used for all three attenuation configurations.   
The SPECT coronal slices were summed over all 64 slices to give images analogous to planar images. 
We obtained HMRs on these summed images in the same way as for the planar and we term these 
“coronal SPECT HMRs”.  The same regions of interest were used for planar and summed coronal SPECT 
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HMRs, with no adjustment between the non-corrected and ACSC SPECT (see Figure 2 for example).  
This enables a direct assessment of the effects of attenuation and scatter correction to be made. 
 
Figure 2: Planar image (left) with corresponding summed coronal SPECT slice images without CT ACSC (middle) and with 
corrections (right).  Note the relative reduction in lung uptake and increased heart contrast on the ACSC image. 
Volumetric HMRs on clinical and phantom SPECT images were calculated using 6cm diameter spherical 
VOIs placed over the left ventricle and cuboid VOIs over the mediastinum (Figure 3).  The placement 
of VOIs was not modified between the ACSC and non-corrected datasets.   
 
Figure 3: Example control SPECT-CT images showing coronal, sagittal and transverse slices centred on the left ventricle, with 
spherical cardiac VOI and rectangular mediastinal VOI shown. 
Planar and SPECT HMR data for the controls were plotted against BMI and the slopes and standard 
errors calculated using linear regression.  The standard errors of the slopes were used to calculate t-
statistics to determine whether each relationship between HMR and BMI (for planar or SPECT) was 
significant at the α = 0.05 level.   To compare slopes, normalisation was necessary since average HMRs 
are much higher for SPECT than planar due to increased contrast.  The SPECT slopes and the standard 
errors were scaled to be consistent with planar data by multiplying by the ratio between the mean 
planar HMR and HMR in question.  The differences between the normalised slopes and their combined 
standard errors were used to determine whether corrections for attenuation and scatter had a 





The appearance of the phantom on planar and non-corrected SPECT images was significantly affected 
by additional attenuation, whereas this was not the case with the attenuation and scatter corrected 
SPECT images (Figure 4).  The HMR on planar imaging was reduced by 20% with the additional PMMA 
chest plate added and by 40% with the plate and water filled breasts added (Figure 4 and Figure 5).  
On the summed coronal SPECT images without CT ACSC this improved to 11% and 21% respectively.  
The summed coronal ACSC SPECT images showed an increase in HMR with additional attenuation, due 
to lower mediastinum counts – the appearance of the images was reasonably preserved.   
Compared to baseline, the volumetric HMR with the additional chest plate and breasts decreased from 
8.8 to 7.6 (13%) on non-corrected SPECT but increased from 9.5 to 10.3 (8%) on ACSC (Figure 5), again 
due to a greater reduction in counts in the mediastinum VOI. 
The decay corrected SPECT cardiac count data (Figure 6), show a much lower drop with additional 
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Figure 4: The effects of attenuation and scatter on planar and ACSC SPECT images of the torso phantom.  The top row 
shows the planar images, middle row the NC summed coronal slices and the bottom row the ACSC summed coronal slices.   
 
 
Figure 5: Phantom heart to mediastinum ratios for the three size configurations, calculated from planar images, summed 
ACSC and non-corrected (NC) coronal SPECT images and volumetric HMRs from ACSC and NC SPECT.  Both the planar and 
non-corrected SPECT HMRs decrease with additional attenuating material. 
 
  
Figure 6: Counts in cardiac volume of interest with ACSC and non-corrected SPECT for the heart insert scanned alone and with 
increasing attenuation within the torso phantom. The decrease in counts when the insert is scanned within the phantom is 



































On planar imaging a negative linear correlation between HMR and BMI is seen (Figure 7), with a slope 
that is significantly different from zero (p <0.01), resulting in a 32% drop in HMR on average between 
BMI of 20 and 35 (  
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Table 2).  In comparison, the drop in HMR over this BMI range with attenuation and scatter corrected 
SPECT was 14% on average for the summed coronal slice method and 16% for the volumetric SPECT 
method (with 6cm diameter spherical VOI).  However, comparison between normalised slope values, 
via a t-statistic calculated from the standard errors of the slopes (Table 3) shows no significant 
difference between planar and either summed coronal ACSC SPECT (p =0.11) or volumetric ACSC 
SPECT (p=0.36). 
Error! Reference source not found. shows the plots of HMR or cardiac counts against BMI for the 
summed coronal SPECT images and SPECT volumetric HMR.  These are displayed with the non-
corrected data on the left and the ACSC data on the right for each method.  The linear fits, and p values 
for slopes being different from zero for planar and SPECT imaging are given in   
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Table 2.  The p-values in show that with the summed non-corrected SPECT coronal slices, there is a 
significant drop in HMR with BMI but with attenuation and scatter correction this is not statistically 
significant.  However, when comparing the slopes for non-corrected and ACSC coronal HMR data 
directly (  
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Table 2) there is no evidence of a statistically significant difference.  SPECT volumetric HMR (spherical 
VOI) data show no significant relationship with BMI either with or without ACSC, and have the highest 
normalised standard errors, possibly due to greater uncertainty in cardiac and mediastinum volume 
of interest placement compared to the other 2D methods.  The coefficients of variation of the HMR 
data (independent of any relationship with BMI) are also higher for the volumetric SPECT data than 



























Table 2: Linear regression between HMR and BMI for planar data and SPECT with and without attenuation and scatter 
correction. 
Quantitative measurement Planar 
HMR 
Summed SPECT 
coronal slices HMR 
Volumetric SPECT HMR 
CT ACSC? n/a Yes No Yes No 
Coefficient of variation  17% 14% 13% 25% 28% 










R2 0.44 0.11 0.28 0.05 0.05 
Normalised slope n/a -0.028 -0.037 -0.034 -0.039 
SE of slope 0.017 0.023 0.017 0.104 0.11 
Normalised SE n/a 0.017 0.015 0.03 0.034 
p-value for non-zero slope <0.01 0.09 <0.01 0.27 0.27 
Predicted drop in value 

















Table 3: Comparison between normalised slopes for planar and SPECT HMR with BMI, and for attenuation and scatter 









Planar HMR vs ACSC 
summed coronal HMR 
0.038 0.022 1.60 0.11 
Planar HMR vs ACSC 
volumetric SPECT HMR 
0.032 
 
0.035 0.932 0.36 
Summed coronal: ACSC vs 
no corrections 
0.008 0.022 0.380 0.71 
Volumetric SPECT: ACSC vs 
no corrections 





Figure 8: Summed coronal HMR with and without ACSC (top), SPECT volumetric HMR with and without ACSC (bottom). 
 
Discussion 
A strength of our study is the inclusion of both phantom and clinical data.  The phantom data was 
acquired under controlled conditions allowing us to investigate the impact of increasing phantom size 
alone with no other sources of variation.  The clinical data applies image reconstruction in more 
realistic conditions to determine whether the effect holds in practice. 
The visual appearance of the torso phantom reconstructed with the summed ACSC SPECT images was 











































































































images; this is particularly apparent on the third configuration with both the PMMA chest plate and 
the water filled breast inserts added.  The counts within the left ventricle insert showed a much 
greater reduction with increasing scatter and attenuation on the non- corrected images compared to 
those reconstructed with ACSC.   Given that this was an anthropomorphic phantom with realistic 
dimensions and activity concentrations, the results can be assumed to hold in individual patients. 
However, when examining our cohort of 29 older adults with normal cognition, the benefit of ACSC 
SPECT is not as apparent.  Although on average, the relationship between BMI and cardiac uptake was 
less obvious with SPECT imaging than planar, there was no evidence that this was statistically 
significant.  It is clear that there is a significant relationship between planar HMR and body mass index, 
so on average we would expect to see lower HMRs in larger people.  However given the substantial 
variation between subjects (an R2 value of 0.44 suggests that less than half the variation is related to 
BMI), it would not be practical to apply a linear correction to the HMR results based on BMI.  This 
variation seems to be even greater with SPECT volumetric HMRs and there is furthermore no 
statistically significant negative slope between SPECT HMR and BMI, which we would expect for data 
without attenuation and scatter correction if this is the cause of the drop seen in planar imaging.  The 
summed coronal slices do show a drop on the non-corrected images, suggesting that the summation 
of the SPECT slices reduces noise in the data.  We recognise that BMI is more complex than the 
increases in size applied to our phantom study and there is likely to be substantial variation in the 
gamma ray interactions of two people of the same BMI.   The size of the left ventricle may also affect 
the activity concentration.  In addition, the inactive background material used in the phantom is not 
fully representative of the activity distribution within patients. 
Variation in uptake between individuals may not be the only explanation for our findings.  The ACSC 
summed coronal SPECT images do not appear noisier than the planar images but do suggest a drop in 
HMR with increasing BMI, albeit not statistically significant.   A possible explanation is errors in the CT 
ACSC that are not seen in the phantom scans.  Motion between SPECT and CT is a possibility, either 
due to volunteers moving slightly or internal mis-registration due to free breathing (e.g. diaphragm) 
or lack of cardiac gating.  The images were examined for mis-registration during reconstruction, but 
this will not detect subtle shifts. 
A further limitation is the truncation of reconstructed SPECT data in some cases, due to the finite field 
of view.  The majority of the older adults (19/29) were not able to tolerate being scanned with their 
arms raised, which is the standard protocol, so the arms were outside the SPECT field of view and not 
taken into account during reconstruction (Figure 9).  The CT field of view is slightly wider, but the CT 
data outside the SPECT field is not used for reconstruction.  In some cases there was further truncation 
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due to body habitus for the largest subjects.  This means that scatter and attenuation correction for 
larger people may be inadequate, and could explain why there appears to be a residual drop in ACSC 
SPECT HMR with increasing BMI (Figure 10).  However, we cannot exclude the possibility that larger 
people may on average be more likely to have true reductions in cardiac uptake, for example due to 
underlying coronary artery disease, for which obesity is a risk factor. 
  
Figure 9: The image on the left is of a volunteer scanned with arms raised, with the whole body within the SPECT and CT 
fields of view.  The image on the right is an example of a larger person scanned with arms by their side.  The arms are 
outside the SPECT field of view so have not been taken into account. 
 
Figure 10: Attenuation and scatter corrected HMR for the volunteers plotted against cross sectional size on CT.  For those 
scanned with arms down there appears to be drop in HMR with size, suggesting inadequate ACSC due to data truncation. 
Conclusion 
In an anthropomorphic torso phantom, increasing the size reduces cardiac uptake on planar images 
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is no longer apparent.  Clinical planar cardiac 123I-MIBG images show a significant inverse relationship 
between cardiac uptake ratios and subject BMI.   SPECT images with attenuation and scatter correction 
applied show no statistically significant drop in cardiac uptake with BMI, but there is considerable 
inter-subject variation and no statistically significant difference between the slopes of HMR against 
BMI for non-corrected and ACSC SPECT.  It may be possible to reduce variation in future studies by 
using a SPECT-CT protocol that is more acceptable to older patients.  This work suggests that ACSC 
SPECT does have the potential to improve cardiac 123I-MIBG quantification, particularly in borderline 
planar cases but much larger studies would be needed to demonstrate this. 
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